IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes
- PMID: 2896213
IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes
Abstract
The purpose of the current study was to characterize lymphokine-activated killer (LAK) activity induced with IL-4/B cell stimulatory factor-1 and to compare IL-4-induced LAK activity with IL-2-induced LAK activity. Culture of murine lymphocytes with high concentrations of IL-4 induced nonspecific lytic activity against a wide variety of tumors. Lytic activity induced by IL-4 increased with increasing concentrations of IL-4 over the range of 1.0 to 25 ng/ml. The kinetics of LAK induction by IL-4 and IL-2 were similar; however, IL-4 was less effective than IL-2 in maintaining lytic activity for longer culture periods and provided lower viable cell yields than did IL-2. Similar to IL-2, IL-4 induced blastogenesis and the generation of large granular lymphocytes, all LAK activity observed was exclusively associated with the large granular lymphocyte fraction, and the cytolytic effector cells were heterogeneous in regards to cell surface phenotype. The majority of IL-4-induced lytic activity was associated with mutually exclusive NK-like (i.e., NK-1.1+ Lyt-2-) and T cell-like (i.e., NK-1.1- Lyt-2+) LAK cells. The precursors for each subset were distinct and expressed the asialo-GM1+ Lyt-2- and the asialo-GM1+ Lyt-2+ phenotypes, respectively. Although IL-4-induced LAK effector cells were morphologically and phenotypically similar to IL-2-induced LAK cells, IL-2 generated equivalent numbers of T cell-like and NK-like LAK cells, whereas IL-4 generated 3.5-fold more T cell-like LAK cells than NK-like LAK cells. It might eventually be possible to exploit the preferential activation of T cell-like LAK by IL-4 for therapeutic advantage.
Similar articles
-
Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.J Immunol. 1988 Aug 15;141(4):1390-7. J Immunol. 1988. PMID: 3260924
-
Generation and characterization of purified adherent lymphokine-activated killer cells in mice.J Immunol. 1989 Mar 1;142(5):1748-54. J Immunol. 1989. PMID: 2783950
-
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.J Immunol. 1987 Jun 1;138(11):3640-5. J Immunol. 1987. PMID: 3495566
-
[Identification and characterization of effector lymphocytes lysing autologous tumor cells].Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-2):1462-8. Gan To Kagaku Ryoho. 1989. PMID: 2658829 Review. Japanese.
-
The biology of human natural killer cells.Ann Ist Super Sanita. 1990;26(3-4):335-48. Ann Ist Super Sanita. 1990. PMID: 2091502 Review.
Cited by
-
Arsenic trioxide enhances the cytotoxic effect of thalidomide in a KG-1a human acute mylogenous leukemia cell line.Oncol Lett. 2010 May;1(3):473-479. doi: 10.3892/ol_00000083. Oncol Lett. 2010. PMID: 21442015 Free PMC article.
-
Biology of natural killer cells.Adv Immunol. 1989;47:187-376. doi: 10.1016/s0065-2776(08)60664-1. Adv Immunol. 1989. PMID: 2683611 Free PMC article. Review.
-
IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity.Br J Cancer. 1990 Oct;62(4):619-23. doi: 10.1038/bjc.1990.341. Br J Cancer. 1990. PMID: 1699593 Free PMC article.
-
Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.Cancer Immunol Immunother. 1991;33(1):45-9. doi: 10.1007/BF01742527. Cancer Immunol Immunother. 1991. PMID: 2021957 Free PMC article.
-
Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro.Br J Cancer. 1989 Jun;59(6):919-21. doi: 10.1038/bjc.1989.194. Br J Cancer. 1989. PMID: 2660898 Free PMC article. No abstract available.